Show simple item record

dc.contributor.authorTabish, TA
dc.contributor.authorDey, P
dc.contributor.authorMosca, S
dc.contributor.authorSalimi, M
dc.contributor.authorPalombo, F
dc.contributor.authorMatousek, P
dc.contributor.authorStone, N
dc.date.accessioned2020-07-23T07:30:04Z
dc.date.issued2020-06-18
dc.description.abstractNanotheranostics, which combines optical multiplexed disease detection with therapeutic monitoring in a single modality, has the potential to propel the field of nanomedicine toward genuine personalized medicine. Currently employed mainstream modalities using gold nanoparticles (AuNPs) in diagnosis and treatment are limited by a lack of specificity and potential issues associated with systemic toxicity. Light-mediated nanotheranostics offers a relatively non-invasive alternative for cancer diagnosis and treatment by using AuNPs of specific shapes and sizes that absorb near infrared (NIR) light, inducing plasmon resonance for enhanced tumor detection and generating localized heat for tumor ablation. Over the last decade, significant progress has been made in the field of nanotheranostics, however the main biological and translational barriers to nanotheranostics leading to a new paradigm in anti-cancer nanomedicine stem from the molecular complexities of cancer and an incomplete mechanistic understanding of utilization of Au-NPs in living systems. This work provides a comprehensive overview on the biological, physical and translational barriers facing the development of nanotheranostics. It will also summarise the recent advances in engineering specific AuNPs, their unique characteristics and, importantly, tunability to achieve the desired optical/photothermal properties.en_GB
dc.description.sponsorshipEngineering and Physical Sciences Research Council (EPSRC)en_GB
dc.identifier.citationPublished online 18 June 2020en_GB
dc.identifier.doi10.1002/advs.201903441
dc.identifier.grantnumberEP/R020965/1en_GB
dc.identifier.urihttp://hdl.handle.net/10871/122090
dc.language.isoenen_GB
dc.publisherWiley Open Accessen_GB
dc.rights© 2020 The Authors. Published by WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.en_GB
dc.subjectdiagnosticsen_GB
dc.subjectgold nanostructuresen_GB
dc.subjectlighten_GB
dc.subjectphotothermal therapyen_GB
dc.subjecttheranosticsen_GB
dc.titleSmart Gold Nanostructures for Light Mediated Cancer Theranostics: Combining Optical Diagnostics with Photothermal Therapyen_GB
dc.typeArticleen_GB
dc.date.available2020-07-23T07:30:04Z
dc.descriptionThis is the final version. Available from Wiley via the DOI in this record. en_GB
dc.identifier.journalAdvanced Scienceen_GB
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/en_GB
dcterms.dateAccepted2020-04-01
rioxxterms.versionVoRen_GB
rioxxterms.licenseref.startdate2020-04-01
rioxxterms.typeJournal Article/Reviewen_GB
refterms.dateFCD2020-07-23T07:24:26Z
refterms.versionFCDVoR
refterms.dateFOA2020-07-23T07:30:15Z
refterms.panelBen_GB
refterms.depositExceptionpublishedGoldOA


Files in this item

This item appears in the following Collection(s)

Show simple item record

© 2020 The Authors. Published by WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim.

This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
Except where otherwise noted, this item's licence is described as © 2020 The Authors. Published by WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.